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Objective: To determine the characteristic clinico-pathologic features of pulmonary carcinoid
tumours in India.
Methods: Retrospective analysis of the clinico-pathologic and radiologic data of patients with
pulmonary carcinoid tumours from the department of Pulmonary Medicine of the Christian
Medical College, a tertiary care teaching hospital in Southern India, over a study period of 3
years (2001e2004).
Results: There were 25 cases of pulmonary carcinoid tumours: typical 22 (88%) and atypical 3
(12%). The ratio of female to male was 0.8:1. There were 3 smokers (all of whom were males)
in the typical carcinoid group and none in the atypical carcinoid group. Haemoptysis and cough
were the commonest presenting symptoms. The common radiologic findings were post-
obstructive pneumonitis or atelectasis, and mass lesion. Carcinoid syndrome was not present
in any patient. Most of the tumours were central (nZ 23; 92%) and in the main bronchi
(nZ 13; 52%). The most common site was the right main bronchus (nZ 9; 36%). Diagnosis
was made by flexible bronchoscopy and bronchial biopsy in 23 patients (92%). The tumour bled
significantly following biopsy in most patients; however, there was no mortality, and only 1
patient required blood transfusion. Surgical option was offered to most; 13 patients (52%)
had pneumonectomy and 4 patients (16%) had lobectomy. A review of large series from the
literature is also presented.
Conclusion: The clinico-pathologic and radiologic features of pulmonary carcinoid tumours are
presented. We report the first series of pulmonary carcinoid tumours from India.
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1612 R. Thomas et al.Introduction The predominant roentgenographic findings were post-Table 1 Mode of presentation
Presenting symptom/sign Patients (no.) (%)
Haemoptysis 20 80
Cough 16 64
Breathlessness 10 40
Others
Chest pain 5 20
Fever 1 4
SVC syndrome 1 4
Carcinoid syndrome 0
Asymptomatic 0
Evidence of bronchial obstruction
Post-obstructive atelectasis
and pneumonitis
13 52
Post-obstructive bronchiectasis 2 8
Mass lesions 9 36
Normal chest radiograph 1 4Bronchial carcinoid tumours are low-grade malignant neo-
plasm comprised neuroendocrine cells. They account for
1e5% of all lung tumours.1,2 About 90% of the carcinoid
tumours are referred to as ‘‘typical’’ carcinoid tumours,
and are well differentiated with rare mitoses, pleomor-
phism, and necrosis.3,4 The remaining 10% are designated
‘‘atypical’’ carcinoids, and are characterised histologically
by increased mitotic activity, nuclear pleomorphism and
disorganisation. The present retrospective study was con-
ducted to determine the characteristic clinico-pathologic
and radiologic features of carcinoid tumours in India. To
the best of our knowledge this is the first case series of pul-
monary carcinoid tumours published from India.
Materials and methods
We reviewed the medical records of 25 patients with
pulmonary carcinoid tumours diagnosed and treated in
the department of Pulmonary Medicine of the Christian
Medical College, Vellore, a major teaching hospital in South
India, over a 3-year period (2001e2004). The data analysed
included patient’s age and sex, smoking history, presenting
symptoms, radiologic appearance, mode of diagnosis,
location of the tumour, tumour spread, immuno-histochem-
ical findings, and methods of treatment. Patients were also
analysed for comparison by type of tumour e typical or
atypical.
Appropriate measures were undertaken to ensure that
patient confidentiality is maintained and the study was the
hospital board.
Results
Among the 25 patients with carcinoid tumour were 14 males
and 11 females; aged 14e56 years (mean age 38.3 years).
The ratio of female to male patients was 0.8:1. Histopath-
ologically, 22 patients (88%; 13 males and 9 female
patients; age range: 14e56 years) had typical carcinoid
tumour, and 3 patients (12%; 1 male and 2 females; age
range: 32e37 years) had an atypical carcinoid tumour.
Smoking
The smoking status was known for 20 patients with typical
carcinoid tumour, of whom 3 (15%) were smokers. The
smoking status of the other 2 patients with typical carcinoid
was unknown. Two patients with atypical carcinoid tumours
were non-smokers while the smoking status of the third was
not known. All the smokers in this series were men.
Mode of presentation
The majority of patients in our series presented with
haemoptysis (nZ 20; 80%) and cough (nZ 16; 64%). The
other symptoms included dyspnoea (nZ 10; 40%), chest
pain (nZ 5; 20%), SVC syndrome (nZ 1; 4%) and fever
(nZ 1; 4%). Carcinoid syndrome was not encountered in any
patient. All patientswere symptomatic at the timeof presen-
tation. The symptoms and signs are summarised in Table 1.obstructive atelectasis and pneumonitis (nZ 13; 52%),
mass lesion (nZ 9; 36%) and bronchiectasis (nZ 2; 8%).
One patient (4%) had a normal chest radiograph.
Method of diagnosis
All patients underwent diagnostic bronchoscopy. The
diagnosis of carcinoid tumour was made using bronchoscopy
and bronchoscopic biopsy in 23 patients (92%). Of those who
underwent bronchoscopic biopsy, 12 patients (52.2%)
developed moderate bleed following bronchoscopic biopsy,
which was controlled by local measures. One patient had
excessive bleeding during the procedure that was con-
trolled, however, he required to be transfused later.
Tumour was not visualised by bronchoscopy in 2
patients. Of these percutaneous needle biopsy was the
mode of diagnosis in 1 patient (4%); and in 1 patient (4%)
diagnosis was by thoracotomy biopsy.
Tumour location
Most of the carcinoid tumours (nZ 21; 84%) arose in the
major bronchi e in 13 (52%) patients, it arose from the
main-stem bronchi, and in 8 (32%) patients, it arose from
lobar bronchi (Table 2). The commonest site was the right
main bronchus (nZ 9; 36%). The tumour arose from the
periphery of the lungs (i.e., at the segmental bronchi or
beyond) in 2 patients (8%). It presented as hilar mass in 2
patients (8%). The tumour was located in the right lung in
14 (56%) patients and in the left lung in 11 (44%) patients.
Tumour spread
Among the 17 patients with typical carcinoid group who
underwent surgery, only one had mediastinal lymph node
involvement as detected by mediastinal sampling at the
time of surgery. Sixteen patients showed no evidence of
mediastinal lymph node involvement or distant metastasis.
One patient had evidence of mediastinal tumour
Table 2 Tumour locationa
Site Central Peripheralb Total
Right lung 12 1 13
Main bronchus 9 e
Intermediate bronchus 2 e
Upper lobe 0 e
Middle lobe 0 e
Lower lobe 1 1
Left lung 9 1 10
Main bronchus 4 e
Upper lobe 0 e
Lingula 1 e
Lower lobe 4 1
Hilar 2
a Data are presented as no.
b Peripheral tumours arising in the segmental bronchus or
beyond.
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CT scan of the thorax was performed in 2 patients with
typical carcinoid who did not undergo surgery. Mediastinal
lymph node involvement was present in 1 patient and
absent in one. In the remaining 3 patients mediastinal
node involvement could not be assessed.
Two patients with atypical carcinoid who underwent
surgery had no lymph node involvement on the basis of
sampling at surgery and the third patient who did not have
surgery extending up to the mediastinum on CT scan.
Immuno-histochemical findings
Information on immuno-histochemical staining was avail-
able in 22 of the 27 patients in the study. Synaptophysin
was positive in 19 of the 20 specimens stained (94.7%),
Chromogranin was positive in 10 of 16 specimens stained
(61.8%), neuron-specific enolase (NSE) was positive in 7 of
11 specimens stained (63.6%), and cytokeratin (CK) was
positive in 5 of 15 specimens stained (33.3%).
Treatment
Surgery was performed in 19 patients (76%) e pneumonec-
tomy in 13 patients (52%) and lobectomy in 4 patients (16%).
In 2 patients (8%), the tumour was considered inoperable on
the operating table due to adhesions and mediastinal
invasion. Five out of 25 patients (20%) refused surgery and
subsequently, were lost to follow-up. Three patients (12%)
underwent chemotherapy and 2 patients who had surgery
(8%) also underwent adjuvant chemotherapy.
Discussion
Our female to male ratio of 0.8:1 contrasts with most other
studies in the literature, which report a slight female
predominance.5e8 One study reported an equal sex ratio.9
The relative rates of typical and atypical carcinoid tumours
in our study were 88:12, which is almost similar to that
reported (90:10) by Fink et al.10 In most other studies,the prevalence of atypical carcinoids was more than
20%.11e13 However, Hurt et al. reported a much lower prev-
alence of only 1% of atypical carcinoid tumours.5
Despite previous reports, endobronchial biopsies were
quite safe in our hands without significant bleeding. When
clinical features and gross bronchoscopic appearance gave
rise to the suspicion of carcinoid, we always proceeded to
perform biopsies after keeping 1:1000 adrenaline and ice-
cold saline ready for use, if required. Almost all patients
had bleeding and 52.2% of patients developed significant
bleeding following endobronchial biopsies. In all cases the
bleeding could be controlled before the bronchoscope was
removed. In 1 patient, while the bleeding came under
control, the situation was compounded by post-broncho-
scopic haemoptysis and he required blood transfusion.
There was no mortality.
Strictly endoluminal typical carcinoids of the lung may
be amenable to bronchoscopic resection using NdeYAG
laser, photodynamic therapy, cryotherapy or brachyther-
apy. However, this may not be feasible in most centres
since it requires expertise in interventional bronchoscopy,
and this was not attempted in our patients.
All patients were symptomatic at presentation, which is
probably explained by the high incidence of central
tumours in our series. In 23 out of 25 patients (92%) in our
series, the tumour arose from the main stem, lobar or
segmental bronchi, and thus was accessible to the bron-
choscope. There were only 2 cases of peripheral tumours.
Most studies have shown a higher incidence of peripheral
tumours.6,10 Marty-Ane et al.14 and McCaughan8 found more
peripheral carciniods than central carcinoids in their series
of 23 and 124 patients, respectively. On the other hand,
Okike et al.,15 in their series reported that only 16% of
203 patients had peripheral carcinoid tumours. Hurt
et al.5 and Descovich et al.16 reported high incidence of
peripheral tumours of 97% and 82.8% in their series of 79
and 35 patients, respectively.
The most common site of involvement was the right
main bronchus in our series. Some of the other series have
found a higher incidence in other parts of bronchial tree.
Ranchod and Levine17 and Fink et al.10 reported that the
right middle lobe involvement was the commonest, while
Okike et al.15 reported that right and left lower lobe
were the most commonly involved.
As in our series, the previous reports3,8,12,18,19 have
noted that the regional nodal involvement in typical carci-
noid tumours was low and ranged from 3 to 20%. Unlike
other series’, 2 out of 3 patients with atypical carcinoids
in our series had no mediastinal lymph node involvement.
However, we feel that the numbers are too small to draw
major conclusions.
In this series, on immuno-histochemical studies, 18/19
specimens (994.7%) stained positive for Synaptophysin, 10/
16 (61.8%) for Chromogrannin and 7/11 (63.6%) for neuron-
specific enolase (NSE), which is similar to other case series.
However, cytokeratin (CK) was positive only in 5/15 (33.3%)
unlike other series where less than 20% are cytokeratin
negative.
One reason for the large number of cases with negative
cytokeratin is that cytokeratin is focally expressed in
neuroendocrine tumours. In this series immunohistochem-
istry was performed in most cases on a bronchial biopsy
Table 3 Data collected from large series in the literature
Source Year No. Age F:M Location (%) Histology (%) Surgery (%)
Cent. Periph. Typ. Atyp. Lob. Pneum.
Hurt et al. 1984 79 47 1.1:1 97 3 99 1 66 13
McCaughon 1985 124 55 1.2:1 37 63 81 19 42 11
Bertelsen 1985 82 45 1.1:1 79 21 79 21 54 6
Harpole et al. 1992 126 53 0.8:1 55 45 66 34 50 12
Mezzetti et al. 1995 32 50.3 1:1 62.5 37.5 84.4 15.6 NA NA
Gould et al. 1998 87 55 0.8:1 NA NA 74 26 69 7
Descovich 2000 35 43 1.6:1 82.8 17.2 85.7 14.3 57.1 17.1
Fink et al. 2000 142 52 1.6:1 68 32 90 10 56 16
Our study 2008 25 38.3 0.8:1 92 8 88 12 16 52
Cent e central; periph e peripheral; typ e typical; atyp e atypical; lob e lobectomy; and pneum e pneumonectomy.
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possible that if the stain was done on a large biopsy or
resection samples, cases with positive staining for cytoker-
atin would increase.
Table 3 summarises 707 cases reported in the literature
in the last 20 years (1984e2001) and compares these
reports with our series.
Conclusion
Pulmonary carcinoid is an uncommon tumour in India and
we have reported the first case series from here. It is
slightly more common in men and occurs frequently in the
central airways causing obstruction. Diagnosis in most cases
was obtained by bronchoscopic biopsy. Surgical excision
was offered to most patients, however, some of them
declined this option.
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